Citation Impact
Citing Papers
Activities of Linezolid against Rapidly Growing Mycobacteria
2001
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Challenges in the Treatment of Chronic Wounds
2015 Standout
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER−/PR−/Her2− Human Breast Cancer Cells
2016
Antimicrobial titanium/silver PVD coatings on titanium
2006
Current Status of the Use of Modalities in Wound Care: Electrical Stimulation and Ultrasound Therapy
2011
Is there evidence for recommending silver-coated urinary catheters in guidelines?
2002
Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis
2007 StandoutNobel
Natural products: An evolving role in future drug discovery
2011 Standout
Oxazolidinone antibiotics
2001
Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria
2004 Standout
In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus☆
2009 StandoutNobel
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
2010
The oxazolidinones: past, present, and future
2011
Antibacterial coatings on titanium implants
2009 Standout
Pre-clinical in vivo evaluation of orthopaedic bioabsorbable devices
2000
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis
2004
Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling☆
2009
Porosity of 3D biomaterial scaffolds and osteogenesis
2005 Standout
Silver ion release from antimicrobial polyamide/silver composites
2004
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Extracellular matrix structure
2015 Standout
A mechanistic study of the antibacterial effect of silver ions onEscherichia coli andStaphylococcus aureus
2000 Standout
Nocardiosis at the Turn of the Century
2009 Standout
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Diastolic Heart Failure in the Elderly
2007
Intrapulmonary penetration of linezolid
2003
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
A large randomized clinical trial of a silver-impregnated urinary catheter: Lack of efficacy and staphylococcal superinfection
1995
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Oxazolidinones: activity, mode of action, and mechanism of resistance
2004 Standout
Diastolic Heart Failure in the Elderly
2007
Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity
2005 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Heart Malformation Is an Early Response to TCDD in Embryonic Zebrafish
2005
Reducing implant-related infections: active release strategies
2006 Standout
Antimycobacterial Plant Terpenoids
2001
Efficacy of silver-coated medical devices
1998
Flavonoids: an overview
2016 Standout
Review of titanium surface modification techniques and coatings for antibacterial applications
2018 Standout
Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor
2007
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug
2004
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
New Drugs for Tuberculosis: Current Status and Future Prospects
2005
De novo design of tyrosine and serine kinase-driven protein switches
2021 StandoutNobel
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
Gender modulates cardiac phenotype development in genetically modified mice
2004
Androgen Contributes to Gender-Related Cardiac Hypertrophy and Fibrosis in Mice Lacking the Gene Encoding Guanylyl Cyclase-A
2003
Global tuberculosis drug development pipeline: the need and the reality
2010
Silver nanoparticles as a new generation of antimicrobials
2008 Standout
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
The Need for New Drugs against Tuberculosis
2001
Rifalazil Treats and Prevents Relapse of Clostridium difficile -Associated Diarrhea in Hamsters
2004
Constituents from Salvia Species and Their Biological Activities
2012 Standout
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Catalytic Asymmetric Synthesis of Phthioceranic Acid, a Heptamethyl-Branched Acid from Mycobacterium tuberculosis
2007 StandoutNobel
Simple and efficient synthesis of new chiral N,N′‐sulfonyl bis‐oxazolidin‐2‐ones
2006
Otorrhea After Insertion of Silver Oxide–Impregnated Silastic Tympanostomy Tubes
1999
Biological Activities of Hydrazone Derivatives
2007 Standout
Intrapulmonary Pharmacokinetics of Linezolid
2002
Investigational Antimicrobial Agents of 2013
2013
Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv
2005
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections
2008
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
2004
In Vitro Activities of Linezolid against Multiple Nocardia Species
2001
Biodegradable metals
2014 Standout
Development potential of rifalazil
2003
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Natural product and natural product derived drugs in clinical trials
2014 Standout
Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
2009 Standout
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit
2008 StandoutNobel
Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial Cells
2008
In Vitro Activity of PNU-100766 (Linezolid), a New Oxazolidinone Antimicrobial, against Nocardia brasiliensis
2001
Tail domains of myosin-1e regulate phosphatidylinositol signaling and F-actin polymerization at the ventral layer of podosomes
2019
Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy
2006 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
In vitro Evaluation of the Antimicrobial Efficacy and Biocompatibility of a Silver-Coated Central Venous Catheter
1994
Androgens and Cardiovascular Disease
2003
Works of Sharon E. Chase being referenced
A Role for the Aryl Hydrocarbon Receptor in Cardiac Physiology and Function as Demonstrated by AhR Knockout Mice
2003
Physeal response to absorbable polydioxanone bone pins in growing rabbits
1999
Myosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation
2016
Evaluation of Rifapentine in Long-Term Treatment Regimens for Tuberculosis in Mice
1999
Bacterial inhibition by electrical activation of percutaneous silver implants
1986
Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine Model
1999
Myosin 1e is a component of the glomerular slit diaphragm complex that regulates actin reorganization during cell-cell contact formation in podocytes
2013
Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model
2000
Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice
2002
Evaluation of Rifalazil in Long-Term Treatment Regimens for Tuberculosis in Mice
2000